Sources sought
Droxidopa Capsules (VA-27-00007975)
36E79726Q0004
Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.
Response deadline
September 4, 2026 at 3:30 PM EDT
Closed 12 days ago. Posted August 28, 2026. Scheduled to archive October 4, 2026.
Description
As published on SAM.gov.
MARKET RESEARCH QUESTIONNAIRE Droxidopa Capsules Company Name:
I am conducting market research for the procurement of Droxidopa Capsules, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC).
This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
Is your Company able to meet the following minimum requirements:
National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?
If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period.
Name of Manufacturer:
Would you be able to provide a letter of commitment from the manufacturer of the offered drug?
Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?
Under NAICS code 325412, is your company size (check one): Large Business
Small Business
If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?
If your company is not the manufacturer, is the manufacturer a small business concern, as defined in FAR Part 2 with an active SAM registration?
Is the offered end product U.S-made, as defined in FAR Part 25?
If not, if the offered product an end product of a Trade Agreements Act designated country, as defined in FAR Part 25?
Can your company meet the following product, bottle size and usage? Please indicate any details or comments.
Item Description Package Size (Capsules per Bottle) Total Estimated Annual Usage (Bottles) 1 Droxidopa 100MG Capsules, ORAL 90 6,160 2 Droxidopa 200MG Capsules, ORAL 90 3,587 3 Droxidopa 300MG Capsules, ORAL 90 3,738 Is your Company interested in submitting a response to a solicitation?
As this is a national standardized contract, our preference is for a base plus four option years to provide our customers with continuity and consistency of product by allowing for long-term committed purchases of your product. If interested, please indicate base year and how many option periods, not to exceed four.
If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date?
If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.
VA intends to require in the solicitation that proposed products are in unit of use package sizes for all line items (90-count bottles). VA defines unit of use package sizes as follows:
Unit of use package sizes must contain a child proof closure (safety cap) and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Please indicate if your company can provide the products above meeting these packaging requirements.
If your company could supply the products in this solicitation in 90-count bottles, but could not meet the unit of use requirements outlined above, please use the space below to indicate the reason and any details. This information is important as it helps the Government consider possible product issues when developing the solicitation.
If you could provide your responses by next Friday, September 4, 2026, it would be greatly appreciated. Please contact me at Andrew.Cazares@va.gov if you have any questions.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 28, 2026
Sources sought
Due September 4, 2026 at 3:30 PM EDT. SAM.gov, notice d19fbd9b49e8440ead8a3715d058f3c7
Points of contact
- Andrew Cazares, Contract Specialistandrew.cazares@va.gov(708)786-4990
Also open from this buyer
- Tacrolimus CapsulesSolicitationNAICS 32541236E79726R0033Closes todaySep 16
- Roflumilast Tablets (VA-27-00006601)Sources soughtNAICS 32541236E79726Q0005Closes tomorrowSep 17
- Ticagrelor TabletsSolicitationNAICS 32541236E79726R0028Closes tomorrowSep 17
- 2027-2028 Influenza Virus VaccineSolicitationNAICS 32541236E79726R0035Closes in 7 daysSep 23
- 36E79726R0032 Lisinopril Tablets (VA-27-00004937)SolicitationNAICS 32541236E79726R0032Closes in 8 daysSep 24